𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reduction of relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in 300 patients

✍ Scribed by Johannes T Brouwer; Frederik Nevens; Frank C Bekkering; Nadine Bourgeois; Hans Van Vlierberghe; Christine J Weegink; Véronique Lefebvre; Jan van Hattum; Jean Henrion; Jean Delwaide; Bettina E Hansen; Solko W Schalm; for the Benelux Study Group on Treatment of Chronic Hepatitis C

Book ID
116650240
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
231 KB
Volume
40
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Better efficacy of a 12-month interferon
Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: A multicenter, controlled, randomized trial
✍ Jean-Louis Payen; Jacques Izopet; Virginie Galindo-Migeot; Valérie Lauwers-Cance 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB 👁 2 views

We studied the efficacy of three interferon alfa-2b (IFN-2b) regimens for the retreatment of patients with chronic hepatitis C (CHC) with prior complete response followed by relapse. Consecutive patients with CHC who had a complete biochemical response but relapse after a first course of 6 months of

Ability of prolonged interferon treatmen
Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trial
✍ Akinori Kasahara; Norio Hayashi; Naoki Hiramatsu; Masahide Oshita; Hideki Hagiwa 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 882 KB

The aim of this study was to determine whether 12 months course of interferon alfa (IFN-a) therapy could improve the beneficial effect of IFN in chronic hepatitis C. Eighty-eight patients were treated with natural IFNa for either 28 weeks (45 cases) or 52 weeks (43 cases). Sustained response was ach